Art

Reichweite

Bereiche

Status

Start

Ende

Finanzierungsart

Studiendesign

Schlagwörter (Tags)

Kurzbeschreibung/Zielsetzung

The indications under investigation are overactive bladder, fecal incontinence, and non-obstructive urinary retention. Refer to
geography-specific labeling for additional details on indications.

There are no investigational devices used in this study, all study products will be used in accordance with the product labeling.

Purpose: Post-market clinical follow-up to confirm long-term safety and performance of the InterStim Micro System for sacral neuromodulation.

Primary Objective for Fecal Incontinence:
• To demonstrate an improvement in Cleveland Clinic
Incontinence Score (CCIS) at 3 months post-implant compared
to baseline
Additional Measures:
• To characterize change in symptoms at follow-up visits
compared to baseline
• To characterize the change in Cleveland Clinic Incontinence
Score (CCIS) at follow-up visits compared to baseline
• To characterize the change in Fecal Incontinence Quality of
Life Questionnaire (FIQoL) at follow-up visits compared to
baseline
• To characterize Patient Global Impression of Improvement
(PGI-I) and patient satisfaction at follow-up visits